- ARTERY 18 Poster Session
- Poster Session I - Special Populations I
- Open access
- Published:
P68 The Hidden Predictor of Cardiovascular Outcome
Artery Research volume 24, page 98 (2018)
Abstract
Background
Hyperuricemia is common in patients with hypertension, diabetes and obesity. Whether it is an independent cardiovascular risk factor (CVRF) or not remains controversial.
Purpose
To determine the prognostic value of uricemia in the setting of acute coronary syndrome (ACS).
Methods
Retrospective single-center study comprising 1187 patients consecutively admitted into a cardiac intensive care unit for ACS, in whom uricemia was measured during hospitalization. Follow-up targeted all-cause mortality (FUM), reinfarction, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and acute heart failure (AHF). Statistical analysis was performed using SPSS, version 25. Results: Mean age was 68.0 ± 13.3y and 30.4% were female. Prevalence of CVRF was as follows: hypertension, 76.9%; diabetes, 33.4%; dyslipidemia, 65.6%; smoking, 35.5%; chronic kidney disease (CKD), 20.5%. Uricemia was 377 ± 119.2 μmol/l, whereas body mass index (BMI) was 27.8 ± 4.4 kg/ m2. In-hospital mortality (IHM) was 6%, while median follow-up time was 6y, encompassing the following event rates: FUM, 36.9%; reinfarction, 19.4%; PCI, 21.1%; CABG, 2.3%; AHF, 16.6%. Uricemia was higher in males (p = 0.001) and in patients with hypertension (p < 0.001), diabetes mellitus (p = 0.009) and CKD (p < 0.001) and lower in patients with dyslipidemia (p = 0.031) and smokers (p = 0.03). Age and BMI displayed weak correlation with uricemia. Hyperuricemia had no effect on the burden of reinfaction, PCI and CABG. In a model of logistic regression including the above-mentioned CVRF, hyperuricemia was an independent predictor of IHM (p = 0.009, Hosmer-Lemeshow p = 0.685), FUM (p < 0.001, Hosmer-Leme-show p - 0.056) and AHF (p = 0.001, Hosmer-Lemeshow p = 0.367).
Conclusion
Hyperuricemia is an independent predictor of mortality and AHF in the setting of ACS.
References
Singh JA. When gout goes to the heart: does gout equal a cardiovascular disease risk factor? Ann Rheum Dis. 2015 Apr;74(4):631–4. doi: 10.1136/annrheumdis-2014-206432.
Skak-Nielsen H, Torp-Pedersen C, Finer N, Caterson ID, Van Gaal L, James WP, Maggioni AP, Sharma AM, Coutinho W, Andersson C. Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. PLoS One. 2013;8(3):e59121. doi: 10.1371/journal.pone.0059121.
Qin L, Yang Z, Gu H, Lu S, Shi Q, Xing Y, Li X, Li R, Ning G, Su Q. Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals. BMC Cardiovasc Disord. 2014 Feb 25;14:26. https://doi.org/10.1186/1471-2261-14-26.
Author information
Authors and Affiliations
Rights and permissions
This is an open access article distributed under the CC BY-NC license https://doi.org/creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sousa, J., Lopes, J., Reis, L. et al. P68 The Hidden Predictor of Cardiovascular Outcome. Artery Res 24, 98 (2018). https://doi.org/10.1016/j.artres.2018.10.121
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.artres.2018.10.121